PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26307135-4	2016	Median intact FGF23 tended to increase with past use of both nonnucleoside reverse-transcriptase inhibitors and protease inhibitors, but tended to decrease with recent use of either tenofovir, efavirenz or lopinavir.	Tenofovir	182-191	fibroblast growth factor 23	Homo sapiens	14-19	
28233741-0	2017	Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism.	Tenofovir	26-35	fibroblast growth factor 23	Homo sapiens	103-108	
26307135-8	2016	Lower levels of intact FGF23 with recent use of tenofovir, efavirenz or lopinavir may reflect their adverse effects on bone and vitamin D metabolism relative to other drugs in their respective drug classes.	Tenofovir	48-57	fibroblast growth factor 23	Homo sapiens	23-28	
24706031-0	2014	Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia.	Tenofovir	43-52	fibroblast growth factor 23	Homo sapiens	0-27	
24535626-2	2014	Fibroblast growth factor 23 (FGF23) causes phosphaturia and increases in response to elevated 1,25-OH(2)D. Vitamin D-binding protein (VDBP) binds to 1,25-OH(2)D, decreasing its biological activity, and is elevated in individuals with higher plasma tenofovir concentrations.	Tenofovir	248-257	fibroblast growth factor 23	Homo sapiens	0-27	
24535626-2	2014	Fibroblast growth factor 23 (FGF23) causes phosphaturia and increases in response to elevated 1,25-OH(2)D. Vitamin D-binding protein (VDBP) binds to 1,25-OH(2)D, decreasing its biological activity, and is elevated in individuals with higher plasma tenofovir concentrations.	Tenofovir	248-257	fibroblast growth factor 23	Homo sapiens	29-34	
22462533-0	2012	Fibroblast growth factor 23 in hypophosphataemic HIV-positive adults on tenofovir.	Tenofovir	72-81	fibroblast growth factor 23	Homo sapiens	0-27	
22462533-4	2012	The aim of the study was to investigate whether FGF-23 might be involved in the aetiology of hypophosphataemia in HIV-positive patients on tenofovir.	Tenofovir	139-148	fibroblast growth factor 23	Homo sapiens	48-54	
21185214-0	2011	Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease.	Tenofovir	38-47	fibroblast growth factor 23	Homo sapiens	14-19	
21185214-3	2011	We evaluated FGF23 plasma concentrations in an HIV-positive patient with neurofibromatosis in whom hypophosphatemia developed during tenofovir therapy.	Tenofovir	133-142	fibroblast growth factor 23	Homo sapiens	13-18